Moneycontrol PRO
HomeNewsBusinessZydus Lifesciences gets USFDA nod for generic medication

Zydus Lifesciences gets USFDA nod for generic medication

The company has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strength of 0.5 g and 1 g, it said in a regulatory filing.

April 24, 2023 / 13:35 IST
Zydus Lifesciences gets USFDA nod for generic medication
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market.

    The company has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strength of 0.5 g and 1 g, it said in a regulatory filing.

    The capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

    As per IQVIA data, Icosapent Ethyl Capsules, 0.5 g and 1 g, had annual sales of USD 1,316 million in the US.

    Shares of the company were trading marginally higher at Rs 518.80 apiece on BSE.

    PTI
    first published: Apr 24, 2023 01:35 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347